Atherosclerosis
Volume 197, Issue 1 , Pages 383-391 , March 2008

Intra-arterial vitamin C prevents endothelial dysfunction caused by ischemia-reperfusion

  • Johannes Pleiner

      Affiliations

    • Department of Clinical Pharmacology, Medical University of Vienna, Austria
    • ,
  • Georg Schaller

      Affiliations

    • Department of Clinical Pharmacology, Medical University of Vienna, Austria
    • ,
  • Friedrich Mittermayer

      Affiliations

    • Department of Clinical Pharmacology, Medical University of Vienna, Austria
    • ,
  • Claudia Marsik

      Affiliations

    • Department of Clinical Pharmacology, Medical University of Vienna, Austria
    • Institute for Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Austria
    • ,
  • Raymond J. MacAllister

      Affiliations

    • Centre for Clinical Pharmacology, University College London, UK
    • ,
  • Stylianos Kapiotis

      Affiliations

    • Institute for Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Austria
    • ,
  • Sophie Ziegler

      Affiliations

    • Department of Angiology, Medical University of Vienna, Austria
    • ,
  • Arnulf Ferlitsch

      Affiliations

    • Department of Clinical Pharmacology, Medical University of Vienna, Austria
    • ,
  • Michael Wolzt

      Affiliations

    • Department of Clinical Pharmacology, Medical University of Vienna, Austria
    • Corresponding Author InformationCorresponding author at: Department of Clinical Pharmacology, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. Tel.: +43 1 40400 2981; fax: +43 1 40400 2998.

Received 30 June 2006 ,Revised 25 May 2007 ,Accepted 19 June 2007.

References 

  1. Lefer AM, Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res. 1996;32:743–751
  2. Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47–95
  3. Kadambi A, Skalak TC. Role of leukocytes and tissue-derived oxidants in short-term skeletal muscle ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2000;278:H435–H443
  4. Szabo C. The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock. 1996;6:79–88
  5. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA. 1989;86:6377–6381
  6. Tomasian D, Keaney JF, Vita JA. Antioxidants and the bioactivity of endothelium-derived nitric oxide. Cardiovasc Res. 2000;47:426–435
  7. Pleiner J, Mittermayer F, Schaller G, MacAllister RJ, Wolzt M. High doses of vitamin C reverse Escherichia coli endotoxin-induced hyporeactivity to acetylcholine in the human forearm. Circulation. 2002;106:1460–1464
  8. Pernow J, Bohm F, Beltran E, Gonon A. l-Arginine protects from ischemia-reperfusion-induced endothelial dysfunction in humans in vivo. J Appl Physiol. 2003;95:2218–2222
  9. Kharbanda RK, Peters M, Walton B, et al. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation. 2001;103:1624–1630
  10. Kharbanda RK, Mortensen UM, White PA, et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation. 2002;106:2881–2883
  11. Bass DA, Parce JW, Dechatelet LR, et al. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol. 1983;130:1910–1917
  12. Hokanson DE, Sumner DS, Strandness DE. An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans Biomed Eng. 1975;22:25–29
  13. Pleiner J, Heere-Ress E, Langenberger H, et al. Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans. Arterioscler Thromb Vasc Biol. 2002;22:95–100
  14. Benjamin N, Calver A, Collier J, et al. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension. 1995;25:918–923
  15. Marsik C, Mayr F, Cardona F, et al. Endotoxaemia modulates Toll-like receptors on leucocytes in humans. Br J Haematol. 2003;121:653–656
  16. Hearse DJ, Maxwell L, Saldanha C, Gavin JB. The myocardial vasculature during ischemia and reperfusion: a target for injury and protection. J Mol Cell Cardiol. 1993;25:759–800
  17. Tsao PS, Aoki N, Lefer DJ, Johnson G, Lefer AM. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation. 1990;82:1402–1412
  18. Kaeffer N, Richard V, Francois A, et al. Preconditioning prevents chronic reperfusion-induced coronary endothelial dysfunction in rats. Am J Physiol. 1996;271:H842–H849
  19. Richard V, Kaeffer N, Hogie M, et al. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist. Br J Pharmacol. 1994;113:869–876
  20. Clancy RM, Leszczynska-Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest. 1992;90:1116–1121
  21. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA. 1991;88:4651–4655
  22. Ohashi Y, Kawashima S, Hirata K, Akita H, Yokoyama M. Nitric oxide inhibits neutrophil adhesion to cytokine-activated cardiac myocytes. Am J Physiol. 1997;272:H2807–H2814
  23. De Caterina R, Libby P, Peng HB, et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 1995;96:60–68
  24. Vinten-Johansen J, Zhao ZQ, Nakamura M, et al. Nitric oxide and the vascular endothelium in myocardial ischemia-reperfusion injury. Ann N Y Acad Sci. 1999;874:354–370
  25. Yataco AR, Corretti MC, Gardner AW, Womack CJ, Katzel LI. Endothelial reactivity and cardiac risk factors in older patients with peripheral arterial disease. Am J Cardiol. 1999;83:754–758
  26. Silvestro A, Scopacasa F, Ruocco A, et al. Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease. Vasc Med. 2003;8:225–232
  27. Garlick PB, Davies MJ, Hearse DJ, Slater TF. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res. 1987;61:757–760
  28. Bertuglia S, Giusti A. Microvascular oxygenation, oxidative stress. NO suppression and superoxide dismutase during postischemic reperfusion. Am J Physiol Heart Circ Physiol. 2003;285:H1064–H1071
  29. Duilio C, Ambrosio G, Kuppusamy P, et al. Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia. Am J Physiol Heart Circ Physiol. 2001;280:H2649–H2657
  30. Wolin MS. Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol. 2000;20:1430–1442
  31. Stroes ES, van Faassen EE, van Londen GJ, Rabelink TJ. Oxygen radical stress in vascular disease: the role of endothelial nitric oxide synthase. J Cardiovasc Pharmacol. 1998;32(Suppl. 3):S14–S21
  32. Smith JA, Weidemann MJ. Further characterization of the neutrophil oxidative burst by flow cytometry. J Immunol Methods. 1993;162:261–268
  33. Ting HH, Timimi FK, Haley EA, et al. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 1997;95:2617–2622
  34. Jackson TS, Xu A, Vita JA, Keaney JF. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res. 1998;83:916–922
  35. Blanchard J, Tozer TN, Rowland M. Pharmacokinetic perspectives on megadoses of ascorbic acid. Am J Clin Nutr. 1997;66:1165–1171
  36. Sherman DL, Keaney JF, Biegelsen ES, et al. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension. 2000;35:936–941
  37. Darko D, Dornhorst A, Kelly FJ, Ritter JM, Chowienczyk PJ. Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in Type II diabetes. Clin Sci (Lond). 2002;103:339–344
  38. Graumlich JF, Ludden TM, Conry-Cantilena C, et al. Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion. Pharm Res. 1997;14:1133–1139
  39. Huang A, Vita JA, Venema RC, Keaney JF. Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem. 2000;275:17399–17406
  40. Pleiner J, Schaller G, Mittermayer F, et al. FFA-induced endothelial dysfunction can be corrected by vitamin C. J Clin Endocrinol Metab. 2002;87:2913–2917
  41. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2:997–1000
  42. Tayeh MA, Marletta MA. Macrophage oxidation of l-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor. J Biol Chem. 1989;264:19654–19658
  43. Byrka-Owczarek K, Steplewska-Mazur K, Krason M, et al. The evaluation of the protective action of antioxidants on small intestine of rabbits experimentally injured by ischemia and reperfusion. J Pediatr Surg. 2004;39:1226–1229
  44. Taha MO, Souza HS, Carvalho CA, et al. Cytoprotective effects of ascorbic acid on the ischemia-reperfusion injury of rat liver. Transplant Proc. 2004;36:296–300
  45. Baltalarli A, Ozcan V, Bir F, et al. Ascorbic acid (vitamin C) and iloprost attenuate the lung injury caused by ischemia/reperfusion of the lower extremities of rats. Ann Vasc Surg. 2006;20:49–55
  46. Bailey DM, Raman S, McEneny J, et al. Vitamin C prophylaxis promotes oxidative lipid damage during surgical ischemia-reperfusion. Free Radic Biol Med. 2006;40:591–600

PII: S0021-9150(07)00396-6

doi: 10.1016/j.atherosclerosis.2007.06.011

Atherosclerosis
Volume 197, Issue 1 , Pages 383-391 , March 2008

Article Tools

* Image Usage & Resolution